In addition, NEAT1 can target miR-152-3p to up-regulate the expression of CDK19 and promote the cell viability, cycle and apoptosis of ovarian cancer cells, which can be reversed by evodiamine [42]. Here, NEAT1 is linked to ovarian carcinoma.